WNT signaling in tumors: the way to evade drugs and immunity

E Martin-Orozco, A Sanchez-Fernandez… - Frontiers in …, 2019 - frontiersin.org
WNT/β-catenin signaling is involved in many physiological processes. Its implication in
embryonic development, cell migration, and polarization has been shown. Nevertheless …

[HTML][HTML] CD47/SIRPα pathway mediates cancer immune escape and immunotherapy

X Jia, B Yan, X Tian, Q Liu, J Jin, J Shi… - International journal of …, 2021 - ncbi.nlm.nih.gov
The adaptive immune checkpoints such as PD-1 (programmed death-1)/PD-L1
(programmed death-ligand 1) play an important role in cancer immunotherapy, whereas …

Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication

P Gowda, S Patrick, SD Joshi, RK Kumawat, E Sen - Cytokine, 2021 - Elsevier
Efforts to understand host factors critical for COVID-19 pathogenesis have identified high
mobility group box 1 (HMGB1) to be crucial for regulating susceptibility to SARS-CoV-2 …

Glial and myeloid heterogeneity in the brain tumour microenvironment

BM Andersen, C Faust Akl, MA Wheeler… - Nature Reviews …, 2021 - nature.com
Brain cancers carry bleak prognoses, with therapeutic advances helping only a minority of
patients over the past decade. The brain tumour microenvironment (TME) is highly …

EGFR‐Induced and c‐Src‐Mediated CD47 Phosphorylation Inhibits TRIM21‐Dependent Polyubiquitylation and Degradation of CD47 to Promote Tumor Immune …

L Du, Z Su, S Wang, Y Meng, F Xiao, D Xu… - Advanced …, 2023 - Wiley Online Library
Tumor cells often overexpress immune checkpoint proteins, including CD47, for immune
evasion. However, whether or how oncogenic activation of receptor tyrosine kinases, which …

Wnts and the hallmarks of cancer

Z Zhong, J Yu, DM Virshup, B Madan - Cancer and Metastasis Reviews, 2020 - Springer
Since the discovery of the first mammalian Wnt proto-oncogene in virus-induced mouse
mammary tumors almost four decades ago, Wnt signaling pathway and its involvement in …

Mechanisms of immune escape and resistance to checkpoint inhibitor therapies in mismatch repair deficient metastatic colorectal cancers

V Amodio, G Mauri, NM Reilly, A Sartore-Bianchi… - Cancers, 2021 - mdpi.com
Simple Summary A subset of colorectal cancers (CRCs) is characterized by a mismatch
repair deficiency that is frequently associated with microsatellite instability (MSI). The …

Glioblastoma immunotherapy targeting the innate immune checkpoint CD47-SIRPα axis

J Hu, Q Xiao, M Dong, D Guo, X Wu… - Frontiers in …, 2020 - frontiersin.org
Glioblastoma Multiforme (GBM) is the most common and aggressive form of intracranial
tumors with poor prognosis. In recent years, tumor immunotherapy has been an attractive …

Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis

H Yang, R Shao, H Huang, X Wang, Z Rong… - Cancer …, 2019 - Wiley Online Library
The use of immunotherapy has achieved great advances in the treatment of cancer.
Macrophages play a pivotal role in the immune defense system, serving both as phagocytes …

PRMT1 driven PTX3 regulates ferritinophagy in glioma

K Lathoria, P Gowda, SB Umdor, S Patrick, V Suri… - Autophagy, 2023 - Taylor & Francis
Mutations in the Krebs cycle enzyme IDH1 (isocitrate dehydrogenase (NADP (+)) 1) are
associated with better prognosis in gliomas. Though IDH1 mutant (IDH1R132H) tumors are …